Home / Inspections / 1275631

FDA Inspection 1275631 — Haupt Pharma Wuelfing GmbH

Haupt Pharma Wuelfing GmbH — FEI 3003183252

The FDA completed an inspection of Haupt Pharma Wuelfing GmbH on June 6, 2023 in Gronau (Leine). The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 6, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gronau (Leine) (Germany)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1088285 (NAI Fri Dec 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1009773 (NAI Fri Mar 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 931397 (VAI Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 877801 (VAI Fri Mar 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 780558 (VAI Fri Apr 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources